Literature DB >> 12634361

Unusual properties of adenovirus E2E transcription by RNA polymerase III.

Wenlin Huang1, S J Flint.   

Abstract

In adenovirus type 5-infected cells, RNA polymerase III transcription of a gene superimposed on the 5' end of the E2E RNA polymerase II transcription unit produces two small (<100-nucleotide) RNAs that accumulate to low steady-state concentrations (W. Huang, R. Pruzan, and S. J. Flint, Proc. Natl. Acad. Sci. USA 91:1265-1269, 1984). To gain a better understanding of the function of this RNA polymerase III transcription, we have examined the properties of the small E2E RNAs and E2E RNA polymerase III transcription in more detail. The accumulation of cytoplasmic E2E RNAs and the rates of E2E transcription by the two RNA polymerases during the infectious cycle were analyzed by using RNase T(1) protection and run-on transcription assays, respectively. Although the RNA polymerase III transcripts were present at significantly lower concentrations than E2E mRNA throughout the period examined, E2E transcription by RNA polymerase III was found to be at least as efficient as that by RNA polymerase II. The short half-lifes of the small E2E RNAs estimated by using the actinomycin D chase method appear to account for their limited accumulation. The transcription of E2E sequences by RNA polymerase II and III in cells infected by recombinant adenoviruses carrying ectopic E2E-CAT (chloramphenicol transferase) reporter genes with mutations in E2E promoter sequences was also examined. The results of these experiments indicate that recognition of the E2E promoter by the RNA polymerase II transcriptional machinery in infected cells limits transcription by RNA polymerase III, and vice versa. Such transcriptional competition and the properties of E2E RNAs made by RNA polymerase III suggest that the function of this viral RNA polymerase III transcription unit is unusual.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634361      PMCID: PMC150658          DOI: 10.1128/jvi.77.7.4015-4024.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

Review 1.  Characteristics of post-transcriptional gene silencing.

Authors:  A Chicas; G Macino
Journal:  EMBO Rep       Date:  2001-11       Impact factor: 8.807

2.  Truncation of the human adenovirus type 5 L4 33-kDa protein: evidence for an essential role of the carboxy-terminus in the viral infectious cycle.

Authors:  R L Finnen; J F Biddle; J Flint
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

Review 3.  The rest is silence.

Authors:  E Bernstein; A M Denli; G J Hannon
Journal:  RNA       Date:  2001-11       Impact factor: 4.942

Review 4.  Nuclear export of adenovirus RNA.

Authors:  T Dobner; J Kzhyshkowska
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

Review 5.  Spliceosomal UsnRNP biogenesis, structure and function.

Authors:  C L Will; R Lührmann
Journal:  Curr Opin Cell Biol       Date:  2001-06       Impact factor: 8.382

6.  Ancient pathways programmed by small RNAs.

Authors:  Phillip D Zamore
Journal:  Science       Date:  2002-05-17       Impact factor: 47.728

7.  An expanding universe of noncoding RNAs.

Authors:  Gisela Storz
Journal:  Science       Date:  2002-05-17       Impact factor: 47.728

Review 8.  The chemical repertoire of natural ribozymes.

Authors:  Jennifer A Doudna; Thomas R Cech
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

Review 9.  Ribonuclease P: unity and diversity in a tRNA processing ribozyme.

Authors:  D N Frank; N R Pace
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

10.  An RNA polymerase III transcription unit located in the upstream control regions of the human proliferating-cell nucleolar protein p120 gene is transcribed in vitro and in vivo.

Authors:  D Lowe; D Henning; R Reddy
Journal:  Eur J Biochem       Date:  1999-11
View more
  3 in total

1.  Viral DNA synthesis-dependent titration of a cellular repressor activates transcription of the human adenovirus type 2 IVa2 gene.

Authors:  C Iftode; S J Flint
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-09       Impact factor: 11.205

2.  Normal human cell proteins that interact with the adenovirus type 5 E1B 55kDa protein.

Authors:  George Hung; S J Flint
Journal:  Virology       Date:  2017-01-27       Impact factor: 3.616

3.  Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery.

Authors:  Li Li; Jia-Ling Huang; Qi-Cai Liu; Pei-Hong Wu; Ran-Yi Liu; Yi-Xin Zeng; Wen-Lin Huang
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.